Dr Adrian Lee
BSc (Med) MBBS (Hons) FRACP PhD, Medical Oncologist
Languages spoken
English, Cantonese
Overview
Clinical interest in genitourinary, brain, plus head and neck cancers.
Adrian is an experienced medical oncologist, specialising in neuro-oncology, head and neck, and genitourinary cancers.
Adrian is an energetic and empathic clinician who is dedicated to offering high-quality patient care. His practise includes helping patients with evidenced-based care in both the Northern Sydney region and regionally in Armidale, NSW.
In terms of the clinical research that Adrian is involved with, this includes working with a global team at the Memorial Sloan Kettering Cancer Center, New York, USA. He also researches malignant brain tumours and clotting disorders in cancer patients at the Bill Walsh Translational Cancer Research Laboratory, Kolling Institute University of Sydney. His research has been recognised with grants and scholarships, including the Mark Hughes Foundation Innovation grant, the Rebecca Cooper Foundation Scholarship, and funding from Sydney Vital Translational Cancer Research.
Research interests
Adrian is working on a research project with a global team at the Memorial Sloan Kettering Cancer Center, New York, USA. He also researches malignant brain tumours and clotting disorders in cancer patients at the Bill Walsh Translational Cancer Research Laboratory, Kolling Institute University of Sydney. His research has been recognised with grants and scholarships, including the Mark Hughes Foundation Innovation grant, the Rebecca Cooper Foundation Scholarship, and funding from Sydney Vital Translational Cancer Research.
Professional memberships
- Executive Committee, Medical Oncology Group of Australia (MOGA)
- Chair of the State Committee in the Royal Australasian College of Physicians (RACP)
- NSW Physician Training Council
- NSW Basic Physician Training Networks Committee
Publications
- Anti‐epidermal growth factor receptor therapy for glioblastoma in adults
- A prospective study of circulating tumor DNA to guide matched targeted therapy in lung cancers
- The intertwined fates of inflammation and coagulation in glioma
- ROS1-Rearranged Non-Small-Cell Lung Cancer, Factor V Leiden, and Recurrent Venous Thromboses.
- Cilengitide with metronomic temozolomide, procarbazine, and standard radiotherapy in patients with glioblastoma and unmethylated MGMT gene promoter in ExCentric, an open-label phase II trial